LLY vs TECH
By Alex · Tickerpine
Eli Lilly and Company vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | TECH |
|---|---|---|
| Price | $1,443.50 | $72.80 |
| Market cap | $1.29T | $11.44B |
| P/E ratio | 46.9 | 66.8 |
| ROE | 86.02% | 8.33% |
| Profit margin | 31.90% | 14.00% |
| Revenue growth | 38.60% | 4.60% |
| Dividend yield | 0.48% | 0.44% |
| Beta | 0.39 | 1.27 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs TECH in plain English
- LLY is the bigger company — about 112.4× the market cap of TECH.
- LLY is cheaper on earnings (P/E 46.9 vs 66.8).
- LLY earns a higher return on equity (86% vs 8%).
- LLY is growing revenue faster (39% vs 5%).
- LLY has the higher dividend yield (0.48% vs 0.44%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.